News

Natus Displays Innovative Neuromonitoring at NCS Conference

Natus Displays Innovative Neuromonitoring at NCS Conference

Natus Unveils Cutting-Edge Technologies at Neurocritical Care Society Conference

Natus Medical Incorporated is set to showcase its latest innovations in ICU solutions at the Neurocritical Care Society's Annual Conference. Attendees will be thrilled to see how Natus continues to lead the way in developing applications for neurocritical care.

Exciting Innovations in Neuromonitoring

At this year’s conference, Natus will highlight several groundbreaking neuromonitoring solutions, marking its entry into the point-of-care EEG market. The display will include impressive technologies such as NeuroWorks ICU solutions, Moberg CNS solutions, the Camino ICP monitor, and Grass MR conditional electrodes, all designed to enhance patient care.

Key Technologies on Exhibit

The suite of technologies presented will demonstrate Natus' commitment to improving patient outcomes in critical care environments:

  • NeuroWorks ICU Solutions provides continuous brain monitoring integrated with real-time EEG data, ensuring clinicians have access to crucial patient information.
  • Moberg CNS Monitor, equipped with CNS Envision software, expands vital sign monitoring to include neurocritical aspects, allowing healthcare professionals to glean insights that lead to better clinical decisions.
  • The Camino ICP Monitor, now in its third generation, will be featured for its reliability and precision in tracking the intracranial pressure of patients under critical care.
  • Grass MR Conditional Cup Electrodes are designed for use in Magnetic Resonance environments, proving safe for patients during EEG testing and subsequent MRI procedures.

Advancing EEG in Neurocritical Care

Natus is enthusiastic about introducing a new point-of-care EEG system that complements its extensive portfolio of ICU solutions. This innovative system aims to facilitate timely brain monitoring, thus equipping clinicians with immediate insights to detect seizure activities in critical environments.

In an effort to enhance its capabilities, Natus has formed a collaboration with Persyst, known for their advanced spike and seizure detection technology. The integration of AI-powered algorithms into the point-of-care EEG system, which is currently under FDA review for 510(k) premarket clearance, signifies a leap forward in clinical efficacy.

Visit Natus at the Conference

Natus will be present at Booth 219 during the conference, inviting healthcare professionals and attendees to come explore its wide-ranging ICU solutions. This is a prime opportunity to learn how Natus is shaping the future of neurocritical care and enhancing patient safety and outcomes.

About Natus Medical Incorporated

Natus is globally recognized for providing innovative solutions that aid healthcare providers in screening, diagnosing, and treating brain and sensory nervous system disorders. Natus prioritizes improving patient care through cutting-edge technology, intensive education, and hands-on support, which in turn uplifts standard practices within clinical settings. To explore the full range of Natus products and services, please visit their website.

Frequently Asked Questions

What is Natus showcasing at the Neurocritical Care Society Conference?

Natus is exhibiting innovations in neuromonitoring technologies, including the NeuroWorks ICU solutions and other groundbreaking devices focused on advancing brain monitoring.

How does Natus's point-of-care EEG system benefit clinicians?

This system facilitates timely brain monitoring and provides immediate insights, helping clinicians to quickly identify seizure activities in critical care settings.

What collaboration has Natus entered regarding EEG technology?

Natus has partnered with Persyst to integrate AI-powered seizure detection algorithms into its new point-of-care EEG system, enhancing diagnostic capabilities.

Where can attendees find Natus at the conference?

Natus will be located at Booth 219 during the Neurocritical Care Society Conference, where visitors can learn more about their products.

What other technologies is Natus highlighting?

The technologies on display include Moberg CNS solutions, Camino ICP monitor, and Grass MR conditional electrodes, all aimed at improving neurocritical care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Cenovus Energy Expands Portfolio with Major Share Acquisition

Updated Category News Views 184

Cenovus Energy Acquires Significant Stake in MEG Energy Cenovus Energy Inc. (TSX: CVE) has recently made a strategic move to acquire 21,723,540 common shares of MEG Energy Corp. ("MEG"), amounting to 8.5% of the total shares outstanding. This acquisition positions Cenovus as a notable shareholder in MEG, reflecting the company’s commitment to growth within the energy...

Continue Reading
Arthur J. Gallagher & Co. Prepares for Q4 2024 Earnings Report

Updated Category News Views 288

Arthur J. Gallagher & Co. Prepares for Q4 2024 Earnings Release Arthur J. Gallagher & Co. (NYSE: AJG) is set to announce its fourth quarter 2024 earnings following the market close on the last day of January 2025. This eagerly awaited financial update will provide insights into the company's performance and strategic direction as it continues to thrive in the dynamic...

Continue Reading
KKR Enhances Tender Offer Strategy for FUJI SOFT Shares

Updated Category News Views 72

KKR Revamps Tender Offer Strategy for FUJI SOFT Shares KKR, a leading global investment firm, has recently made an important change to its tender offer for FUJI SOFT INCORPORATED's common shares. This strategic update appears to provide shareholders with new options and greater flexibility in the tendering process. Decoding the Amendment Statement Alongside the tender...

Continue Reading
TC Transcontinental Sells Industrial Packaging Division

Updated Category News Views 178

TC Transcontinental Makes Strategic Move in Packaging Sector TC Transcontinental has announced an important step in its growth strategy by selling its industrial packaging operations to Hood Packaging Corporation. This significant transaction is valued at US$95 million, which translates to approximately C$132 million, subject to adjustments related to working capital....

Continue Reading
Investing in Wingstop: A Journey Over the Last Five Years

Updated Category News Views 116

Investing in Wingstop: A Journey Over the Last Five Years Wingstop (NASDAQ: WING) has demonstrated impressive growth over the past five years, exceeding market expectations with an annualized return of 34.38%. The company now boasts a market capitalization of $11.69 billion, highlighting its strong performance in the fast-casual dining sector. Your Investment in WING:...

Continue Reading